Sign In
Buy EAR
$2.57
+0 (+0%)
At Close: May 14, 2024
Eargo to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
04:30pm, Thursday, 11'th Feb 2021
SAN JOSE, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced it will
Eargo Announces Preliminary Unaudited Fourth Quarter and Full Year 2020 Net Revenue and Preliminary Gross Systems Shipped
04:01pm, Monday, 11'th Jan 2021
SAN JOSE, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced its pre
Eargo to Present at 39th Annual J.P. Morgan Healthcare Conference
04:01pm, Monday, 21'st Dec 2020
SAN JOSE, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced it wil
Eargo Ranks First for Best Company Culture in Comparably Awards
04:01pm, Friday, 18'th Dec 2020
Eargo is also named to “Best Company for Women” and “Best CEOs” list Eargo is also named to “Best Company for Women” and “Best CEOs” list
Deep Pharma Intelligence Names Nanox, TransMedics, Outset, Eargo, and Silkroad as Best Health-Tech Companies to Watch in 2021-2022
08:00am, Tuesday, 15'th Dec 2020
LONDON--(BUSINESS WIRE)--Deep Pharma Intelligence names Nanox Imaging (NASDAQ:NNOX), TransMedics, Inc. (NASDAQ: TMDX), Outset Medical, Inc. (NASDAQ:OM), Eargo, Inc. (NASDAQ:EAR), and Silk Road Medical
